» Articles » PMID: 26686912

Survival Impact of Postoperative Body Mass Index in Gastric Cancer Patients Undergoing Gastrectomy

Overview
Journal Eur J Cancer
Specialty Oncology
Date 2015 Dec 22
PMID 26686912
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The relationship between preoperative body mass index (BMI) and the survival of postoperative gastric cancer patients is not clear. Furthermore, the survival impact with postoperative BMI is not known, even though weight loss is inevitable after gastrectomy.

Methods: Patients who underwent gastrectomy for gastric cancer between 2000 and 2008 were included in the study (n = 1909). Patients were divided into three groups based on their BMIs: low (<18.5 kg/m(2)), normal (18.5-24.9 kg/m(2)), and high BMI (≥ 25.0 kg/m(2)). Patient survival was compared according to BMI at two time points: baseline and 1 year after surgery.

Results: Regarding BMI 1 year after surgery, overall survival, disease-specific survival, and recurrence-free survival were longer in the high BMI group than the low and normal BMI groups. In a Cox proportional hazards model, adjusting for the patient's age, sex, type of surgery, tumour stage, histology, curative resection, and BMI at baseline, a high BMI 1 year after surgery was associated with lower overall mortality compared to normal BMI (hazard ratio 0.51; 95% confidence interval, 0.26-0.98). However, BMI at baseline was not an independent prognostic factor.

Conclusion: BMI 1 year after surgery significantly predicted the long-term survival of patients with gastric cancer compared with the preoperative BMI.

Citing Articles

Association of preoperative body mass index with postoperative complications and survival for patients with gastric cancer: A systematic review and meta-analysis.

Li Z, Cui L, Sun J, Liu W PLoS One. 2025; 20(1):e0317985.

PMID: 39874306 PMC: 11774357. DOI: 10.1371/journal.pone.0317985.


Effect of Oral Nutritional Supplements Composed of High Protein on Body Weight Loss After Gastrectomy.

Kikuchi S, Takata N, Kakiuchi Y, Kuroda S, Kashima H, Tanabe S In Vivo. 2024; 39(1):426-432.

PMID: 39740898 PMC: 11705125. DOI: 10.21873/invivo.13845.


Total gastrectomy patients had a lower diet volume and greater diet frequency than distal gastrectomy patients after 6 months.

Kim Y, Jeong S, Jung E, Park T, Lee J, Kim T Medicine (Baltimore). 2024; 103(51):e40878.

PMID: 39705432 PMC: 11666135. DOI: 10.1097/MD.0000000000040878.


Global Leadership Initiative on Malnutrition Criteria and Immunonutritional Status Predict Chemoadherence and Survival in Stage II/III Gastric Cancer Treated with XELOX Chemotherapy.

Yun J, Song G, Son M, Lee M Nutrients. 2024; 16(20).

PMID: 39458464 PMC: 11510382. DOI: 10.3390/nu16203468.


Changes in Skeletal Muscle Mass in the First 3 Months Following Gastrointestinal Cancer Surgery: A Prospective Study.

Xu X, Liu W, Yates P Ann Surg Oncol. 2024; 31(13):8651-8663.

PMID: 39230851 PMC: 11549114. DOI: 10.1245/s10434-024-16109-8.